eMedevents
  • 126009+ Medical Conferences
  • 251 Specialties
  • 32176 Organizers
  • 144953 Speakers
  • 154 Countries
  • 4300 Cities
42003+
CME Conference Registrations Sold
Home  >  Conferences  >  3rd Annual Non-alcoholic Steatohepatitis (NASH) Summit 2019

3rd Annual Non-alcoholic Steatohepatitis (NASH) Summit 2019

Apr 22 - 25, 2019   |   Boston, Massachusetts  United States Of America
Organized by : Hanson Wade
Specialties : Gastroenterology   |   Medicine   |   Hepatology
 
Conference Brochure

3rd Annual Non-alcoholic Steatohepatitis (NASH) Summit 2019 is organized by Hanson Wade and will be held from Apr 22 - 25, 2019 at Hilton Boston Logan Airport, Boston, Massachusetts, United States of America.

Conference Description :
This Conference will cover every element of NASH drug development from early discovery to late-stage clinical development and commercialization. Providing an unparalleled learning and networking experience; this exclusive forum is the unrivaled opportunity to network with 300 drug developers from 140 organizations and accelerate the development of your NASH candidate pipeline.

Be at the forefront of the insights from 60+ leading experts as they share their learnings on:
• Commercialization challenges, the payers perspective and the investors' criteria for business in the current and future NASH market.
• The non-invasive diagnostics landscape and regulatory considerations on biomarker adoption for clinical trials.
• Computational methods and artificial intelligence to increase the efficiency of drug development.
• Scientific rationale of combinational therapeutics as the necessary treatment strategy for NASH to inform pairing decisions.
• Identification and recruitment of "high risk" patients needed to optimize clinical success and demonstrate sufficient efficacy.

Covering every element from basic science to commercialization; the 3rd Annual NASH Summit Boston is the most comprehensive forum to provide you with the data, insight, and lessons needed to inform the acceleration of your NASH candidate pipeline:
• Contextualize the progress of the leading candidates beyond data alone to understand patient recruitment strategies, commercialization considerations and hurdles addressed prior to success.
• Understand how to build the confidence of investors and evaluate the payers’ perspective on reimbursement.
• Improve drug efficacy in both early and late stage NASHby identifying and validating novel targets & drug mechanisms of action.

Prices:
Gold Pass: Full Access (Conference Days + Seminar Day and Discussion Day): USD 4597.0
Silver Pass: Conference + Seminar Day: USD 3898.0
Silver Pass: Conference + Discussion Day (2 Workshops): USD 3898.0
Bronze Pass: Conference Only: USD 2899.0
Bronze Pass: Seminar Day Only: USD 1399.0
Bronze Pass: Discussion Day Only (2 Workshops): USD 1399.0

Time: 8:00 am to 5:00 pm

View All Speaking

Gregory Tesz
Gregory Tesz

Endocrinology, Metabolism and Diabetes

Jagpreet Chhatwal
Jagpreet Chhatwal

Healthcare Management

Jeffrey T. Irelan
Jeffrey T. Irelan

Cell and Developmental Biology

Julia Brosnan
Julia Brosnan

Biochemistry and Molecular Genetics

Registration Desk

Contact No. : 16174554188
Email:
info@hansonwade.com

View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

Hilton Boston Logan Airport
One Hotel Drive
Boston, Massachusetts, United States Of America

Official Hotel

Hilton Boston Logan Airport,

One Hotel Drive,

Boston, Massachusetts, United States of America 02128,

+1 617-568-6700

Plan Your Travel

 
 
 
 

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Hilton Boston Logan Airport
0.08 miles from venue
Embassy Suites Hotel Boston At Logan Airport
0.48 miles from venue
Close

Session Details

Session Topic Start Time End Time Location Description Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news